• 1. Pyrimidines. Part II. Nucleophilic substitution reactions of ethyl 4-chloro-2-methylthiopyrimidine-5-carboxylate
  R. S. Shadbolt,T. L. V. Ulbricht J. Chem. Soc. C 1967 1172

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

Ethyl 2,4-diaminopyrimidine-5-carboxylate (CAS No. 15400-54-1): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Ethyl 2,4-diaminopyrimidine-5-carboxylate (CAS No. 15400-54-1) is a significant compound in the realm of pharmaceutical chemistry, serving as a crucial intermediate in the synthesis of various biologically active molecules. Its unique structural framework, featuring both amino and carboxylate functional groups, makes it a valuable building block for the development of novel therapeutic agents.

The compound's chemical structure consists of a pyrimidine core substituted with an ethyl ester at the 5-position and two amino groups at the 2- and 4-positions. This configuration provides multiple reactive sites, enabling diverse chemical modifications that can be tailored to meet specific pharmacological requirements. The presence of both amino groups allows for further functionalization via reductive amination, amidation, or condensation reactions, while the ester group can be hydrolyzed to yield the corresponding carboxylic acid derivative.

In recent years, Ethyl 2,4-diaminopyrimidine-5-carboxylate has garnered attention in the development of antiviral and anticancer agents. Its pyrimidine scaffold is closely related to nucleobases found in DNA and RNA, making it a logical candidate for interfering with nucleic acid synthesis or modifying enzyme activity. For instance, derivatives of this compound have been explored as inhibitors of enzymes such as dihydrofolate reductase (DHFR), which plays a critical role in DNA synthesis and repair.

One notable application of Ethyl 2,4-diaminopyrimidine-5-carboxylate is in the synthesis of kinase inhibitors. Protein kinases are enzymes that regulate numerous cellular processes, and their dysregulation is often associated with diseases such as cancer. By designing molecules that selectively inhibit specific kinases, researchers aim to develop targeted therapies with improved efficacy and reduced side effects. The compound's versatile structure allows for the introduction of substituents that can modulate binding affinity and selectivity against various kinase targets.

Recent advancements in medicinal chemistry have highlighted the utility of Ethyl 2,4-diaminopyrimidine-5-carboxylate in the development of next-generation antibiotics. The rise of antibiotic-resistant pathogens has necessitated the discovery of novel antimicrobial agents. Pyrimidine derivatives have shown promise in this area due to their ability to disrupt bacterial cell wall synthesis or interfere with essential metabolic pathways. Researchers have reported on the synthesis of novel ethyl 2,4-diaminopyrimidine-5-carboxylate-based compounds that exhibit potent activity against Gram-positive and Gram-negative bacteria.

The synthetic pathways for Ethyl 2,4-diaminopyrimidine-5-carboxylate have also seen significant improvements. Modern synthetic methods emphasize efficiency, sustainability, and scalability, ensuring that pharmaceutical manufacturers can produce this intermediate cost-effectively while minimizing environmental impact. Techniques such as catalytic hydrogenation, microwave-assisted synthesis, and flow chemistry have been employed to optimize reaction conditions and improve yields.

The role of computational chemistry in designing derivatives of Ethyl 2,4-diaminopyrimidine-5-carboxylate cannot be overstated. Molecular modeling tools allow researchers to predict the binding modes of their compounds to biological targets with high accuracy. This enables rational drug design by identifying key interactions between the drug molecule and its target protein or nucleic acid. Such simulations have been instrumental in guiding synthetic efforts toward more potent and selective agents.

In conclusion, Ethyl 2,4-diaminopyrimidine-5-carboxylate (CAS No. 15400-54-1) is a multifaceted compound with broad applications in pharmaceutical research and development. Its unique structural features make it an invaluable intermediate for synthesizing antiviral, anticancer, anti-inflammatory, and antimicrobial agents. As our understanding of biological systems continues to evolve, so too will the applications of this versatile building block in addressing global health challenges.

• 15400-50-7(5-Pyrimidinecarboxylicacid, 4-amino-2-cyano-, ethyl ester)
• 18588-61-9(2,4-Diaminopyrimidine-5-carboxylic acid)
• 71406-78-5(Ethyl 4-amino-2-chloropyrimidine-5-carboxylate)
• 65195-35-9(4-Aminopyrimidine-5-carboxylic Acid Ethyl Ester)
• 714975-53-8(Methyl 4-aminopyrimidine-5-carboxylate)
• 87846-99-9(5-Pyrimidinecarboxylic acid, 2,4,6-tris(dimethylamino)-, methyl ester)
• 57401-76-0(Ethyl 2-aminopyrimidine-5-carboxylate)
• 20737-41-1(4-Aminopyrimidine-5-carboxylic acid)
• 776-53-4(ethyl 4-amino-2-(methylsulfanyl)pyrimidine-5-carboxylate)
• 5472-46-8(Ethyl 4-amino-2-methylpyrimidine-5-carboxylate)